← Open Payments lookup

MARK ASHBY: Open Payments

NPI 1063417616 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$759 in 25 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $211 · 2025 $759

Food & beverage: $759
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$310
Axsome Therapeutics, Inc.3$155
Otsuka America Pharmaceutical, Inc.5$114
Vanda Pharmaceuticals Inc.3$80
E.R. Squibb & Sons, L.L.C.2$41
Alkermes, Inc.1$27
Takeda Pharmaceuticals U.S.A., Inc.1$17
Neurocrine BioSciences, Inc.1$16

Products named: CAPLYTA, Auvelity, REXULTI, FANAPT, COBENFY, ARISTADA, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across FL — which companies pay providers there.